<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Protein substitute for children and adults with phenylketonuria - Yi, SHL - 2015 | Cochrane Library</title> <meta content="Protein substitute for children and adults with phenylketonuria - Yi, SHL - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004731.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Protein substitute for children and adults with phenylketonuria - Yi, SHL - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004731.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004731.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Protein substitute for children and adults with phenylketonuria" name="citation_title"/> <meta content="Sarah HL Yi" name="citation_author"/> <meta content="Emory Genetics Metabolic Nutrition Program" name="citation_author_institution"/> <meta content="Rani H Singh" name="citation_author"/> <meta content="Emory University School of Medicine" name="citation_author_institution"/> <meta content="rsingh@genetics.emory.edu" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD004731.pub4" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/02/27" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004731.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004731.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004731.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Food, Formulated; Dietary Proteins [*administration &amp; dosage]; Phenylalanine [*blood]; Phenylalanine Hydroxylase [deficiency]; Phenylketonurias [diet therapy, *therapy]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004731.pub4&amp;doi=10.1002/14651858.CD004731.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="0TJL4CWK";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004731\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004731\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","hr","pl","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004731.pub4",title:"Protein substitute for children and adults with phenylketonuria",firstPublishedDate:"Feb 27, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Cystic Fibrosis and Genetic Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004731.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004731.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004731.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004731.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004731.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004731.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004731.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004731.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004731.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004731.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004731.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004731.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004731.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004731.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2336 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004731.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/full#CD004731-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/full#CD004731-sec-0089"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/full#CD004731-sec-0015"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/full#CD004731-sec-0019"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/full#CD004731-sec-0020"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/full#CD004731-sec-0041"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/full#CD004731-sec-0088"> Discussion </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004731.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Protein substitute for children and adults with phenylketonuria</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/information#CD004731-cr-0002">Sarah HL Yi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004731.pub4/information#CD004731-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Rani H Singh</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004731.pub4/information/en#CD004731-sec-0096">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 27 February 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004731.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004731.pub4">https://doi.org/10.1002/14651858.CD004731.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004731-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004731-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004731-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004731-abs-0008">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004731-abs-0001" lang="en"> <section id="CD004731-sec-0001"> <h3 class="title" id="CD004731-sec-0001">Background</h3> <p>Phenylketonuria is an inherited metabolic disorder characterised by an absence or deficiency of the enzyme phenylalanine hydroxylase. The aim of treatment is to lower blood phenylalanine concentrations to the recommended therapeutic range to prevent developmental delay and support normal growth. Current treatment consists of a low‐phenylalanine diet in combination with a protein substitute which is free from or low in phenylalanine. Guidance regarding the use, dosage, and distribution of dosage of the protein substitute over a 24‐hour period is unclear, and there is variation in recommendations among treatment centres. This is an update of a Cochrane review first published in 2005, and previously updated in 2008. </p> </section> <section id="CD004731-sec-0002"> <h3 class="title" id="CD004731-sec-0002">Objectives</h3> <p>To assess the benefits and adverse effects of protein substitute, its dosage, and distribution of dose in children and adults with phenylketonuria who are adhering to a low‐phenylalanine diet. </p> </section> <section id="CD004731-sec-0003"> <h3 class="title" id="CD004731-sec-0003">Search methods</h3> <p>We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register which consists of references identified from comprehensive electronic database searches and hand searches of relevant journals and abstract books of conference proceedings. We also contacted manufacturers of the phenylalanine‐free and low‐phenylalanine protein substitutes for any data from published and unpublished randomised controlled trials. </p> <p>Date of the most recent search of the Group's Inborn Errors of Metabolism Trials Register: 03 April 2014. </p> </section> <section id="CD004731-sec-0004"> <h3 class="title" id="CD004731-sec-0004">Selection criteria</h3> <p>All randomised or quasi‐randomised controlled trials comparing: any dose of protein substitute with no protein substitute; an alternative dosage; or the same dose, but given as frequent small doses throughout the day compared with the same total daily dose given as larger boluses less frequently. </p> </section> <section id="CD004731-sec-0005"> <h3 class="title" id="CD004731-sec-0005">Data collection and analysis</h3> <p>Both authors independently extracted data and assessed trial quality.</p> </section> <section id="CD004731-sec-0006"> <h3 class="title" id="CD004731-sec-0006">Main results</h3> <p>Three trials (69 participants) are included in this review. One trial investigated the use of protein substitute in 16 participants, while a further two trials investigated the dosage of protein substitute in a total of 53 participants. Due to issues with data presentation in each trial, described in full in the review, formal statistical analyses of the data were impossible. Investigators will be contacted for further information. </p> </section> <section id="CD004731-sec-0007"> <h3 class="title" id="CD004731-sec-0007">Authors' conclusions</h3> <p>No conclusions could be drawn about the short‐ or long‐term use of protein substitute in phenylketonuria due to the lack of adequate or analysable trial data. Additional data and randomised controlled trials are needed to investigate the use of protein substitute in phenylketonuria. Until further evidence is available, current practice in the use of protein substitute should continue to be monitored with care. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004731-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004731-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD004731-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD004731-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004731-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD004731-abs-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/pl#CD004731-abs-0005">Polski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004731-abs-0002" lang="en"> <h3>The impact of protein substitute on the nutrition status, growth, and neuropsychological performance of children and adults with phenylketonuria </h3> <p>People with phenylketonuria (PKU) who follow a low‐phenylalanine diet are required to take protein substitute to ensure adequate consumption of protein, energy, and other nutrients. The need for protein substitute has been established through clinical experience and observational data. Randomised, controlled trials are needed to confirm this need as well as its proper dosage and frequency of use. We performed a systematic review of randomised control trials investigating the impact of the use, dosage, and distribution of protein substitute on physical and neuropsychological outcomes in the treatment of PKU. Trials of children and adults diagnosed with PKU in the newborn period who were treated early and continuously were included. We planned to pool the results of the trials to estimate treatment effect. Three trials met the inclusion criteria for the review. One trial evaluated the impact of protein substitute versus no protein substitute on neuropsychological status, plasma amino acid concentrations, and nutrient intake. The remaining two trials investigated the impact of differing dosages of protein substitute on plasma amino acid concentrations and nutrient intake. No trials investigating daily protein substitute distribution were eligible for inclusion in the review. Results are presented in text form only since adequate information for data pooling was not provided. The investigators will be contacted for further information. Currently data are insufficient to reach any conclusions regarding the use, dosage, and distribution of protein substitute in the treatment of PKU. Further randomized or controlled clinical trials are needed to provide evidence for the effectiveness, dosage, and distribution of protein substitute in the treatment of PKU. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004731-sec-0089" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004731-sec-0089"></div> <h3 class="title" id="CD004731-sec-0090">Implications for practice</h3> <section id="CD004731-sec-0090"> <p>No conclusions can be made about the short‐ or long‐term use of protein substitute in PKU due to the lack of adequate trial data. Current practice in the use of protein substitute should continue to be observed and monitored with care until further evidence is available from current and future included trials. Likewise, people with PKU should continue to take the amount of protein substitute as advised by their healthcare professionals. </p> </section> <h3 class="title" id="CD004731-sec-0091">Implications for research</h3> <section id="CD004731-sec-0091"> <p>Large RCTs are needed to investigate the use of protein substitute in PKU. Due to the relatively small numbers of people with this condition, it is recommended that a multicentre approach be adopted. It is important that both long‐ and short‐term outcomes are considered in future trials. To assist in ensuring the appropriateness of future trials, it would be useful to involve people with PKU and their caregivers in the design of the trials. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004731-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004731-sec-0015"></div> <section id="CD004731-sec-0016"> <h3 class="title" id="CD004731-sec-0016">Phenylketonuria</h3> <p>Phenylketonuria (PKU) (PKU; OMIM 261600) is a rare, autosomal recessive disorder that, if untreated, can lead to severe mental retardation, eczema, seizures, and behavioural disorders (<a href="./references#CD004731-bbs2-0061" title="PaineRS . The variability in manifestations of untreated patients with phenylketonuria (phenylpyruvic aciduria). Pediatrics1957;20(2):290‐302. [MEDLINE: 13452670] ">Paine 1957</a>). PKU is most often caused by a mutation in the phenylalanine hydroxylase (EC 1.14.16.1) (PAH) gene, resulting in little to no liver PAH activity. Consequently, phenylalanine metabolism is impaired, plasma concentrations of phenylalanine rise above 120 µmol/L (2 mg/dL), and the brain and other tissues have increased concentrations of phenylalanine (<a href="./references#CD004731-bbs2-0069" title="ScriverCR , KaufmanS . Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: ScriverCR , BeaudetAL , SlyWS , ValleD editor(s). The Metabolic &amp; Molecular Bases of Inherited Disease. 8th Edition. New York: McGraw‐Hill, 2001:1667‐724. ">Scriver 2001</a>). Treatment of PKU necessitates the initiation of dietary phenylalanine restriction and tyrosine supplementation within the first few weeks of life to prevent disease progression (<a href="./references#CD004731-bbs2-0034" title="BickelH , GerrardJ , HickmansEM . Influence of phenylalanine intake on phenylketonuria. Lancet1953;265(6790):812‐3. ">Bickel 1953</a>; <a href="./references#CD004731-bbs2-0063" title="PietzJ , DunckelmannR , RuppA , RatingD , MeinckHM , SchmidtH , et al. Neurological outcome in adult patients with early‐treated phenylketonuria. Journal of Pediatrics1998;157(10):824‐30. [MEDLINE: 9809823] ">Pietz 1998</a>). </p> <p>Despite successful treatment, lack of diet adherence has been linked to elevated plasma phenylalanine levels and adverse sequelae throughout the lifespan of people with PKU, particularly children and females of childbearing age (<a href="./references#CD004731-bbs2-0062" title="PenningtonBF , vanDoorninckWJ , McCabeLL , McCabeER . Neuropsychological deficits in early treated phenylketonuric children. American Journal of Mental Deficiency1985;89(5):467‐74. ">Pennington 1985</a>; <a href="./references#CD004731-bbs2-0037" title="FehrenbachAM , PetersonL . Parental problem‐solving skills, stress, and dietary compliance in phenylketonuria. Journal of Consulting and Clinical Psychology1989;57(2):237‐41. ">Fehrenbach 1989</a>; <a href="./references#CD004731-bbs2-0052" title="LegidoA , TonyesL , CarterD , SchoemakerA , DiGeorgeA , GroverWD . Treatment variables and intellectual outcome in children with classic phenylketonuria. A single‐center‐based study. Clinical Pediatrics1993;32(7):417‐25. ">Legido 1993</a>). Relaxation of the diet leads to poor performance in school, decreased attention span, and lower intellectual function (IQ) (<a href="./references#CD004731-bbs2-0051" title="KrauseW , EpsteinC , AverbookA , DembureP , ElsasL . Phenylalanine alters the mean power frequency of electroencephalograms and plasma L‐dopa in treated patients with phenylketonuria. Pediatric Research1986;20(11):1112‐6. ">Krause 1986</a>; <a href="./references#CD004731-bbs2-0038" title="GriffithsP , PatersonL , HarvieA . Neuropsychological effects of subsequent exposure to phenylalanine in adolescents and young adults with early‐treated phenylketonuria. Journal of Intellectual Disability Research1995;39(5):365‐72. ">Griffiths 1995</a>). Effects on the unborn foetus of a pregnant mother with uncontrolled PKU are reminiscent of foetal alcohol syndrome: small head size, mental retardation, heart disease, growth retardation, and facial dysmorphia (<a href="./references#CD004731-bbs2-0054" title="LipsonAH , YuJS , O'HalloranMT , WilliamsR . Alcohol and phenylketonuria. Lancet1981;317(8222):717‐8. [MEDLINE: 6110928] ">Lipson 1981</a>; <a href="./references#CD004731-bbs2-0066" title="RouseB , LockhartL , MatalonR , AzenC , KochR , HanleyW , et al. Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations. Journal of Inherited Metabolic Disease1990;13(3):289‐91. [MEDLINE: 2122088] ">Rouse 1990</a>; <a href="./references#CD004731-bbs2-0053" title="LevyHL , GhavamiM . Maternal phenylketonuria: a metabolic teratogen. Teratology1996;53(3):176‐84. ">Levy 1996</a>). </p> <p>Phenylketonuria affects people throughout the world with varying incidence and severity, and many countries routinely screen newborns for PKU (<a href="./references#CD004731-bbs2-0072" title="WaisbrenSE , NoelK , FahrbachK , CellaC , FrameD , DorenbaumA , et al. Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta‐analysis. Molecular Genetics and Metabolism2007;92(1‐2):63‐70. [MEDLINE: 17591452] ">Waisbren 2007</a>). Given the more than 531 mutations already identified in the PAH gene (<a href="./references#CD004731-bbs2-0060" title="PAHdb Curatorial Team. Phenylalanine Hydroxylase Locus KnowledgeBase. www.pahdb.mcgill.ca (accessed October 3, 2007). ">PAH database 2007</a>), there is a wide variation in disease severity, with residual PAH activity ranging from less than 2% up to 70% of full activity (<a href="./references#CD004731-bbs2-0040" title="GuldbergP , ReyF , ZschockeJ , RomanoV , FrancoisB , MichielsL , et al. A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype‐based prediction of metabolic phenotype. American Journal of Human Genetics1998;63(1):71‐9. ">Guldberg 1998</a>). Individuals with classical PKU exhibit very low or no PAH activity, and plasma phenylalanine concentrations exceed 1000 µmol/L when untreated (<a href="./references#CD004731-bbs2-0069" title="ScriverCR , KaufmanS . Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: ScriverCR , BeaudetAL , SlyWS , ValleD editor(s). The Metabolic &amp; Molecular Bases of Inherited Disease. 8th Edition. New York: McGraw‐Hill, 2001:1667‐724. ">Scriver 2001</a>), whereas those with milder forms of PKU, termed hyperphenylalanaemia, have partial PAH activity, and plasma phenylalanine concentrations do not exceed 1000 µmol/L when untreated (<a href="./references#CD004731-bbs2-0069" title="ScriverCR , KaufmanS . Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: ScriverCR , BeaudetAL , SlyWS , ValleD editor(s). The Metabolic &amp; Molecular Bases of Inherited Disease. 8th Edition. New York: McGraw‐Hill, 2001:1667‐724. ">Scriver 2001</a>). In the present review the term PKU encompasses both classical PKU and hyperphenylalaninaemia. </p> </section> <section id="CD004731-sec-0017"> <h3 class="title" id="CD004731-sec-0017">Dietary Management of PKU</h3> <p>The ultimate goal of diet management is to achieve plasma phenylalanine within recommended concentrations while maintaining adequate nutrition for normal growth and development (<a href="./references#CD004731-bbs2-0058" title="Medical Research Council Working Party on Phenylketonuria. Recommendations on the dietary management of phenylketonuria. Archives of Disease in Childhood1993;68(3):426‐7. ">MRC 1993</a>; <a href="./references#CD004731-bbs2-0059" title="National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16‐18, 2000. NIH Consensus Statement2001;108(4):972‐82. ">NIH 2000</a>). First used to manage PKU in 1951 (<a href="./references#CD004731-bbs2-0034" title="BickelH , GerrardJ , HickmansEM . Influence of phenylalanine intake on phenylketonuria. Lancet1953;265(6790):812‐3. ">Bickel 1953</a>), the cornerstone of the treatment is restriction of dietary phenylalanine, plus a protein substitute to supply missing essential amino acids and sometimes other nutrients. </p> <p>The average dietary intake of phenylalanine in the US among all ages and both sexes is 3.4 g/day (3400 mg/day) (<a href="./references#CD004731-bbs2-0036" title="Panel onMacronutrients , Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, D.C. National Academies Press2002. ">DRIs 2002</a>). For people with PKU, the amount of phenylalanine in the diet must be restricted, depending upon the level of PAH activity, to maintain recommended plasma phenylalanine concentrations. Those with classical PKU must reduce dietary phenylalanine to 0.2 to 0.5 g/day (200 to 500 mg/day) whereas those with hyperphenylalanaemia can tolerate more than 0.5 g/day (500 mg/day (<a href="./references#CD004731-bbs2-0069" title="ScriverCR , KaufmanS . Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: ScriverCR , BeaudetAL , SlyWS , ValleD editor(s). The Metabolic &amp; Molecular Bases of Inherited Disease. 8th Edition. New York: McGraw‐Hill, 2001:1667‐724. ">Scriver 2001</a>). </p> <p>Over‐restriction of phenylalanine can lead to poor growth, mild to moderate osteoporosis, and other effects of malnutrition (<a href="./references#CD004731-bbs2-0041" title="HanleyWB , LinsaoL , DavidsonW , MoesCA . Malnutrition with early treatment of phenylketonuria. Pediatr Research1970;4(4):318‐27. ">Hanley 1970</a>; <a href="./references#CD004731-bbs2-0070" title="SibingaMS , FriedmanCJ , SteiselIM , BakerEC . The depressing effect of diet on physical growth in phenylketonuria. Developmental Medicine and Child Neurology1971;13(1):63‐70. ">Sibinga 1971</a>). Thus, small portions of foods containing low or moderate amounts of protein, including fruits, vegetables, grains, potatoes, and specialized low‐protein foods, are recommended to provide the amount of phenylalanine tolerated by each individual. With the exception of many fruits and vegetables, one gram of protein in food contains approximately 50 mg of phenylalanine (<a href="./references#CD004731-bbs2-0073" title="WeetchE , MacdonaldA . The determination of phenylalanine content of foods suitable for phenylketonuria. Journal of Human Nutrition and Dietetics2006;19(3):229‐36. ">Weetch 2006</a>). A diet restriction limiting phenylalanine to 250 mg, therefore, would allow for a total of 5 g of natural (intact) protein per day. To comply with this restriction, foods high in protein, such as meat, poultry, fish, milk, nuts, and eggs, are generally eliminated from the diet and a synthetic protein substitute (called a medical food or amino acid mixture) lacking phenylalanine supplies much of the essential amino acid needs. </p> <p>Protein substitute typically provides 52% to 80% of total dietary protein (<a href="./references#CD004731-bbs2-0039" title="GropperSS , AcostaPB , Clarke‐SheehanN , WenzE , ChengM , KochR . Trace element status of children with PKU and normal children. Journal of the American Dietetic Association1988;88(4):459‐65. ">Gropper 1988</a>; <a href="./references#CD004731-bbs2-0068" title="SchulzB , BremerHJ . Nutrient intake and food consumption of adolescents and young adults with phenylketonuria. Acta Paediatrica1995;84(7):743‐8. ">Schulz 1995</a>; <a href="./references#CD004731-bbs2-0056" title="MacDonaldA . Diet and compliance in phenylketonuria. European Journal Pediatrics2000 Oct;159(Suppl 2):S136‐41. ">MacDonald 2000</a>) and the majority of essential and conditionally essential amino acids. In many cases these products also contain carbohydrate, fat, vitamins, and minerals. New varieties of protein substitutes are emerging to improve adherence, touted as having better taste, convenience, energy and nutrient contents, variety of choices, and packaging. Restriction of dietary phenylalanine without an adequate supply of protein substitute has been associated with inadequate intakes of multiple nutrients, including vitamin B12, thiamin, riboflavin, vitamin B6, folate, magnesium, and protein ((<a href="./references#CD004731-bbs2-0039" title="GropperSS , AcostaPB , Clarke‐SheehanN , WenzE , ChengM , KochR . Trace element status of children with PKU and normal children. Journal of the American Dietetic Association1988;88(4):459‐65. ">Gropper 1988</a>; <a href="./references#CD004731-bbs2-0068" title="SchulzB , BremerHJ . Nutrient intake and food consumption of adolescents and young adults with phenylketonuria. Acta Paediatrica1995;84(7):743‐8. ">Schulz 1995</a>), which can lead to deficiencies (<a href="./references#CD004731-bbs2-0042" title="HanleyWB , FeigenbaumA , ClarkeJT , SchoonheytW , AustinV . Vitamin B12 deficiency in adolescents and young adults with phenylketonuria. Lancet1993;342(8877):997. ">Hanley 1993</a>; <a href="./references#CD004731-bbs2-0033" title="AungTT , KliedA , McGinnJ , McGinnT . Vitamin B12 deficiency in an adult phenylketonuric patient. Journal of Inherited Metabolic Disease1997;20(4):603‐4. ">Aung 1997</a>; <a href="./references#CD004731-bbs2-0065" title="RobinsonM , WhiteFJ , ClearyMA , WraithE , LamWK , WalterJH . Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet. Journal of Pediatrics2000;136(4):545‐7. [MEDLINE: 10753257] ">Robinson 2000</a>) and poor growth (<a href="./references#CD004731-bbs2-0032" title="ArnoldGL , VladutiuCJ , KirbyRS , BlakelyEM , DelucaJM . Protein insufficiency and linear growth restriction in phenylketonuria. Journal of Pediatrics2002;141(2):243‐6. ">Arnold 2002</a>). </p> <p>Whether the protein needs are greater for people with PKU continues to be an area of debate. Observational studies of children with PKU aged two months to fifteen years have shown adequate and consistent growth in height over time when consuming protein, a large proportion of which comes from protein substitutes, at levels at or above general population recommendations. Adequate growth is defined as attaining a height‐for‐age percentile within the normal range, and consistent growth is defined as following a consistent height‐for‐age growth curve over time (<a href="./references#CD004731-bbs2-0050" title="KindtE , LundeHA , GjessingLR , HalvorsenS , LieSO . Fasting plasma amino acid concentrations in PKU children on two different levels of protein intake. Acta Paediatrica Scandinavica1988;77(1):60‐6. ">Kindt 1988</a>; <a href="./references#CD004731-bbs2-0031" title="AcostaPB , YannicelliS , SinghR , MofidiS , SteinerR , DeVincentisE , et al. Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy. Journal of the American Dietetic Association2003;103(9):1167‐73. [MEDLINE: 12963945] ">Acosta 2003</a>; <a href="./references#CD004731-bbs2-0035" title="DobbelaereD , MichaudL , DebrabanderA , VanderbeckenS , GottrandF , TurckD , et al. Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria. Journal of Inherited Metabolic Disease2003;26(1):1‐11. ">Dobbelaere 2003</a>; <a href="./references#CD004731-bbs2-0046" title="HuemerM , HuemerC , MoslingerD , HuterD , Stockler‐IpsirogluS . Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature. Journal of Inherited Metabolic Disease2007 Oct;30(5):694‐9. ">Huemer 2007</a>). If protein needs are increased in this population, it is likely due to the bioavailability, biological value, and net protein utilization of the protein source (i.e., protein substitute) (<a href="./references#CD004731-bbs2-0049" title="KindtE , HolmH , HalvorsenS , LieSO . Net protein utilization determined by rat bioassay of a protein hydrolysate and a diet for children with phenylketonuria. British Journal of Nutrition1985;54(2):349‐53. ">Kindt 1985</a>; <a href="./references#CD004731-bbs2-0064" title="PrzyrembelH , BremerHJ . Nutrition, physical growth, and bone density in treated phenylketonuria. European Journal of Pediatrics2000;159(Suppl 2):S129‐35. ">Przyrembel 2000</a>; <a href="./references#CD004731-bbs2-0045" title="HoeksmaM , VanRijnM , VerkerkPH , BoschAM , MulderMF , deKlerkJB , et al. The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria. Journal of Inherited Metabolic Disease2005;28(6):845‐54. ">Hoeksma 2005</a>). People with PKU consuming free amino acids have shown increased urinary nitrogen (N) loss, and healthy adults have shown increased oxidation and decreased overall protein synthesis compared with comparison groups consuming the same amount of N from intact protein (<a href="./references#CD004731-bbs2-0047" title="JonesBJ , LeesR , AndrewsJ , FrostP , SilkDB . Comparison of an elemental and polymeric enteral diet in patients with normal gastrointestinal function. Gut1983;24(1):78‐84. [MEDLINE: 6401257] ">Jones 1983</a>, <a href="./references#CD004731-bbs2-0057" title="MetgesCC , El‐KhouryAE , SelvarajAB , TsayRH , AtkinsonA , ReganMM , et al. Kinetics of L‐[1‐(13)C]leucine when ingested with free amino acids, unlabeled or intrinsically labeled casein. American Journal of Physiology, Endocrinology and metabolism2000;278(6):E1000‐9. [MEDLINE: 10827001] ">Metges 2000</a>). However, a recent study of adults with PKU taking free amino acid‐based protein substitute and adults without PKU taking protein from intact sources, both at 0.8 g protein equivalent/kg body weight/day infused intravenously (Note: the gram weight of free amino acids was multiplied by a factor of 0.8 to calculate protein equivalency), showed no differences in protein turnover, oxidation, and net protein balance (<a href="./references#CD004731-bbs2-0071" title="vanRijnM , HoeksmaM , SauerP , SzczerbakB , GrossM , ReijngoudDJ , et al. Protein metabolism in adult patients with phenylketonuria. Nutrition2007;23(6):445‐53. ">van Rijn 2007</a>). </p> <p>There is considerable agreement that consumption of protein substitute should be evenly spread throughout the day to optimise protein utilization for anabolism and to control plasma phenylalanine concentrations (<a href="./references#CD004731-bbs2-0055" title="MacDonaldA . Diet and Phenylketonuria, Birmingham University. PhD thesis1999. ">MacDonald 1999</a>). In one study, people with PKU typically consuming one to two doses of protein substitute shifted to three equal doses of protein substitute for one day; this shift resulted in a decrease in total urinary N excretion of 4% to 28%, controlling for N intake in eight of ten free‐living participants. In turn, N balance increased or stayed constant for nine of ten participants (<a href="./references#CD004731-bbs2-0067" title="SchoefferA , HerrmannME . Effect of dosage and timing of amino acid mixtures on nitrogen retention in patients with phenylketonuria. Journal of Nutritional Medicine1994;4(4):415‐8. ">Schoeffer 1994</a>). Adding support to this finding, Herrmann and colleagues also found decreased total urinary N excretion, controlling for N intake, when a patient consumed a third of her daily protein substitute at a time compared with the entire daily protein substitute at once. Maximum <sup>13</sup>C‐exhalation, indicating amino acid oxidation, was also lower in the five hours after taking only a third of the daily protein for breakfast (<a href="./references#CD004731-bbs2-0043" title="HerrmannME , BrosickeHG , KellerM , MonchE , HelgeH . Dependence of the utilization of a phenylalanine‐free amino acid mixture on different amounts of single dose ingested. A case report. European Journal of Pediatrics1994;153(7):501‐3. ">Herrmann 1994</a>). </p> </section> <section id="CD004731-sec-0018"> <h3 class="title" id="CD004731-sec-0018">Importance</h3> <p>Since treatment guidelines vary both between and within different countries (<a href="./references#CD004731-bbs2-0058" title="Medical Research Council Working Party on Phenylketonuria. Recommendations on the dietary management of phenylketonuria. Archives of Disease in Childhood1993;68(3):426‐7. ">MRC 1993</a>; <a href="./references#CD004731-bbs2-0059" title="National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16‐18, 2000. NIH Consensus Statement2001;108(4):972‐82. ">NIH 2000</a>), justification for the use, dosage, and distribution of protein substitute is essential for optimal, cost‐effective treatment of PKU. In this review, we will investigate data obtained from relevant randomised, controlled clinical trials in an attempt to resolve discrepancies in treatment guidelines. This is an update of a Cochrane review first published in 2005, and previously updated in 2008 (<a href="./references#CD004731-bbs2-0074" title="Rutherford , Poustie . Protein substitute for children and adults with phenylketonuria. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD004731.pub2] ">Rutherford 2005</a>; <a href="./references#CD004731-bbs2-0075" title="YiSHL , SinghRH . Protein substitute for children and adults with phenylketonuria. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD004731.pub3] ">Yi 2008</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004731-sec-0019" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004731-sec-0019"></div> <p>To assess the benefits and adverse effects of the following in children and adults with PKU who are adhering to a low‐phenylalanine diet: </p> <p> <ol id="CD004731-list-0001"> <li> <p>protein substitute compared with no protein substitute;</p> </li> <li> <p>a high dose of protein substitute compared with a lower dose;</p> </li> <li> <p>protein substitution given as frequent, small doses throughout the day compared with the same total daily dose given as larger boluses less frequently. </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004731-sec-0020" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004731-sec-0020"></div> <section id="CD004731-sec-0021"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004731-sec-0022"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs), both published and unpublished. Trials where quasi‐randomisation methods, such as alternation, are used will be included if there is sufficient evidence that the treatment and control groups are comparable in terms of clinical and nutritional status. </p> </section> <section id="CD004731-sec-0023"> <h4 class="title">Types of participants</h4> <p>Individuals of any age with PKU and other forms of phenylalanine hydroxylase deficiency diagnosed by the Guthrie test or another recognised, validated screening test, in whom dietary treatment was initiated early in infancy and continued. </p> </section> <section id="CD004731-sec-0024"> <h4 class="title">Types of interventions</h4> <p>Supplementation of a low‐phenylalanine diet with:</p> <p> <ol id="CD004731-list-0002"> <li> <p>any dose of protein substitute that has been compared with no protein substitute;</p> </li> <li> <p>a dose of protein substitute compared with an alternative dose;</p> </li> <li> <p>the same dose of protein substitution, but given as frequent, small doses throughout the day, compared with the same total daily dose given as larger boluses less frequently. </p> </li> </ol> </p> <p>A post hoc change was made to the interventions previously outlined in this review. Initially the intervention was to compare a high dose of protein substitute (greater than or equal to 3 g of amino acids per kg per day based on the highest dose recommended by Medical Research Council (MRC) guidelines) with a lower dose (less than 3 g of amino acids per kg per day). This was changed as it was recognised that this practice has changed and continues to change since the publication of the MRC guidelines, and lower protein substitute doses than those quoted in the MRC report are being used (<a href="./references#CD004731-bbs2-0058" title="Medical Research Council Working Party on Phenylketonuria. Recommendations on the dietary management of phenylketonuria. Archives of Disease in Childhood1993;68(3):426‐7. ">MRC 1993</a>). </p> </section> <section id="CD004731-sec-0025"> <h4 class="title">Types of outcome measures</h4> <section id="CD004731-sec-0026"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD004731-list-0003"> <li> <p>Weight gain, body mass index, z scores, centiles, other indices of nutritional status or growth </p> </li> <li> <p>Measures of neuropsychological performance</p> </li> </ol> </p> </section> <section id="CD004731-sec-0027"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD004731-list-0004"> <li> <p>Blood phenylalanine concentrations</p> </li> <li> <p>Blood amino acid concentrations other than phenylalanine</p> </li> <li> <p>Energy and nutrient intake</p> </li> <li> <p>Brain amino acid concentrations</p> </li> <li> <p>Measures of eating behaviour</p> </li> <li> <p>Measures of quality of life</p> </li> <li> <p>Death</p> </li> </ol> </p> <p>As yet we have been unable to enter data into meta‐analyses. However, when this is possible, outcome data from different trials will be compared at using similar time points based on both data availability and relevancy to the outcome measure. For long‐term follow up studies, reported outcome data will be grouped at multiple time points during the year and annually thereafter. </p> </section> </section> </section> <section id="CD004731-sec-0028"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004731-sec-0029"> <h4 class="title">Electronic searches</h4> <p>Relevant trials were sought from the Group's Inborn Errors of Metabolism Trials Register using the term: PKU. </p> <p>This Inborn Errors of Metabolism Register is compiled from electronic searches of the Cochrane Central Register of Controlled Trials<i>(</i> CENTRAL<i>)</i> (updated each new issue of <i>The Cochrane Library</i> ), weekly searches of MEDLINE, and the prospective hand searching of one journal: <i>The Journal of Inherited Metabolic Disease</i>. Unpublished work was identified by searching through the abstract books of the Society for the Study of Inborn Errors of Metabolism conference and the SHS Inborn Error Review Series. For full details of all searching activities for the register, please see the relevant section of the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/CF/frame.html" target="_blank">Cochrane Cystic Fibrosis and Genetic Disorders Group Module</a>. </p> <p>Date of most recent search of the Group's Inborn Errors of Metabolism Trials Register: 03 April 2014. </p> </section> <section id="CD004731-sec-0030"> <h4 class="title">Searching other resources</h4> <p>Additional RCTs were sought from reference lists as well as abstract books from groups and societies interested in inborn errors of metabolism. European and US Manufacturers of the phenylalanine‐free and very low‐phenylalanine protein substitutes were asked whether they had data from published and unpublished RCTs on file. Companies contacted for previous versions of this review were: SHS International, Liverpool, UK; Vitaflo Ltd, Liverpool, UK; Mead Johnson, Middlesex, UK; Milupa, Wiltshire,UK; UCB Pharma, Hertfordshire, UK; Glaxo Smithkline, Middlesex, UK; and Ross Products Division, Ohio, USA. Companies contacted for the current version were: Nutricia North America, Maryland, USA; Vitaflo USA, New York, USA; Vitaflo International Ltd, Liverpool, UK; and Abbott Nutrition, Ohio, USA. Contact authors of all included trials were approached for any further information, if appropriate. </p> </section> </section> <section id="CD004731-sec-0031"> <h3 class="title" id="CD004731-sec-0031">Data collection and analysis</h3> <section id="CD004731-sec-0032"> <h4 class="title">Selection of studies</h4> <p>Both authors independently selected the trials to be included in the review.</p> </section> <section id="CD004731-sec-0033"> <h4 class="title">Data extraction and management</h4> <p>Using standard data acquisition forms, we each independently extracted data. We reached consensus through discussion regarding any disagreements on the suitability of a trial for inclusion in the review or on its quality. </p> </section> <section id="CD004731-sec-0034"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We each assessed the methodological quality of the included trial, using a method described by Jüni (<a href="./references#CD004731-bbs2-0048" title="JüniP , AltmanDG , EggerM . Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ2001;323(7303):42‐6. ">Jüni 2001</a>). In particular, we examined details of the randomisation method, method of allocation concealment, the degree of blinding, whether intention‐to‐treat analyses were possible from the available data, and whether the number of participants lost to follow up or subsequently excluded from the trial was recorded. </p> </section> <section id="CD004731-sec-0035"> <h4 class="title">Measures of treatment effect</h4> <p>When data are available we plan to undertake the following analyses.</p> <p>For binary outcomes, we aim to calculate a pooled estimate of the treatment effect for each outcome across trials (the odds of an outcome among treatment allocated participants to the corresponding odds among controls). For continuous outcomes, we plan to record either mean change from baseline for each group or mean post‐treatment/intervention values and standard deviation for each group. Then, where appropriate, we will calculate a pooled estimate of treatment effect by calculating the mean difference. </p> </section> <section id="CD004731-sec-0036"> <h4 class="title">Unit of analysis issues</h4> <p>Three trials were included in the review. Data from each trial were not presented in a way that could be used for formal statistical analysis, therefore results are presented in the text of this review only. Issues with the data provided included combining outcome data across trial arms or different studies, omitting data, and providing descriptive statistics that are incompatible with the method of analysis used for this review (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>; <a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>; <a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> <section id="CD004731-sec-0037"> <h4 class="title">Dealing with missing data</h4> <p>In a future update, it may be possible to include more data from the included trials, and the lead investigators have been or will be contacted to provide individual patient data. </p> <p>In order to allow an intention‐to‐treat analysis, we will seek data on the number of participants, by allocated treatment group, irrespective of compliance and whether or not the participant will be later thought to be ineligible or otherwise excluded from treatment or follow up. </p> </section> <section id="CD004731-sec-0038"> <h4 class="title">Assessment of heterogeneity</h4> <p>Statistical heterogeneity between trial results will be quantified by using the I<sup>2</sup> statistic (<a href="./references#CD004731-bbs2-0044" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). </p> </section> <section id="CD004731-sec-0039"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Trials of the use of protein substitute in participants who have 'relaxed' their diet will be analysed separately, if sufficient trials are identified to allow a subgroup analysis. This group will consist of adolescents/adults with PKU who consistently have blood phenylalanine concentrations above 700 µmol/L. </p> </section> <section id="CD004731-sec-0040"> <h4 class="title">Sensitivity analysis</h4> <p>We plan to perform a sensitivity analysis based on the methodological quality of the trials, including and excluding quasi‐randomised trials. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004731-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004731-sec-0041"></div> <section id="CD004731-sec-0042"> <h3 class="title">Description of studies</h3> <section id="CD004731-sec-0043"> <h4 class="title">Results of the search</h4> <p>The searches identified 88 references, of which three trials (seven references), including a total of 69 participants, met the inclusion criteria for this review (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>; <a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>; <a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). To the best of our knowledge, there are currently no ongoing studies eligible for this review. </p> </section> <section id="CD004731-sec-0044"> <h4 class="title">Included studies</h4> <section id="CD004731-sec-0045"> <h5 class="title">Supplementation of a low‐phenylalanine diet with any dose of protein substitute that has been compared with no protein substitute </h5> <p>One trial, conducted by Schindeler and colleagues, provided data on the impact of protein substitute usage (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). Although the primary objective of the Schindeler trial was to study the impact of large neutral amino acid supplementation, the interventions in two of the four trial arms met the criteria for inclusion in this review. This trial investigated the neuropsychological and biochemical outcomes of 16 participants ages 11 to 45 years when on and off protein substitute each for 14 days. </p> </section> <section id="CD004731-sec-0046"> <h5 class="title">Supplementation of a low phenylalanine diet with a dose of protein substitute compared with an alternative dose </h5> <p>Two trials investigated variation in dosage of protein substitute (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>; <a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>). Prince employed a two‐phase trial assessing the effects of a new protein substitute which had a lower protein content (10 g protein equivalent to 400 kcal/100 g dry powder) than the control product (a 50% reduction in protein equivalent/100 g dry powder) in 28 children with PKU aged 4 years to 10 years. All children were prescribed protein intakes meeting the US RDA 1989. Only phase one (the first two of five years) was an RCT (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>). MacDonald conducted a RCT with a cross‐over design that compared the effects of a higher dose of protein from protein substitute (2 g protein equivalent/kg body weight/day) with a lower dose (1.2 g/kg/day) using the same protein substitute. A total of 25 children aged 2 to 10 years remaining on their current protein substitute participated (<a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>). </p> </section> <section id="CD004731-sec-0047"> <h5 class="title">Supplementation of a low‐phenylalanine diet with the same dose of protein substitution, but given as frequent small doses throughout the day compared with the same total daily dose given as larger boluses less frequently </h5> <p>No trials were eligible for inclusion.</p> </section> </section> <section id="CD004731-sec-0048"> <h4 class="title">Excluded studies</h4> <p>Of the remaining 81 references identified by the search, 50 were discounted as not being relevant to the review and three were duplicate references. On further examination another 25 references (24 trials) were excluded as not relevant and are listed in the '<a href="#CD004731-sec-0048">Excluded studies</a>' section of the review. Three of the 25 references were excluded because they were not RCTs or quasi‐randomised trials (<a href="./references#CD004731-bbs2-0011" title="ClemensPC , Heddrich‐EllerbrokM , WachtelV , LinkRM . Plasma amino acids in adolescents and adults with phenylketonuria on three different levels of protein intake. Acta Paediatrica Scandinavica1991;80(5):577‐80. ">Clemens 1991</a>; <a href="./references#CD004731-bbs2-0004" title="AcostaPB , YannicelliS . Protein intake affects phenylalanine requirements and growth of infants with phenylketonuria. Acta Paediatrica1994;407:66‐7. ">Acosta 1994</a>; <a href="./references#CD004731-bbs2-0025" title="SHS , Royal Hospital for Sick Children (Glasgow), Alder Hey Children's Hospital (Liverpool), Hospital for Sick Children Great Ormond Street (London), Royal Victoria Hospital (Belfast), The Children's Hospital (Sheffield). A multicentre study to evaluate and compare the nutritional adequacy of XP Analog and Lofenelac in the dietary management of infants with phenylketonuria (PKU). XP Analog and XP Analog LCP ‐ a compilation of abstracts2001. ">SHS 2001</a>); 18 references (17 studies) were excluded as the interventions did not meet the inclusion criteria (<a href="./references#CD004731-bbs2-0016" title="MacDonaldA , FergusonC , RylanceG , MorrisAA , AsplinD , HallSK , et al. Are tablets a practical source of protein substitute in phenylketonuria?. Archives of Disease in Childhood2003;88(4):327‐9. ">MacDonald 2003a</a>; <a href="./references#CD004731-bbs2-0008" title="BaumgartnerC , BohmC , BaumgartnerD , MariniG , WeinbergerK , OlgemollerB , et al. Supervised machine learning techniques for the classification of metabolic disorders in newborns. Bioinformatics2004;20(17):2985‐96. ">Baumgartner 2004</a>; <a href="./references#CD004731-bbs2-0017" title="MacDonaldA , LilburnM , DalyA , HallSK , HendrikszC , ChakrapaniA , et al. Does ready to drink protein substitute improve compliance in PKU [abstract]. Society for the Study of Inborn Errors of Metabolism 42nd Annual Symposium; 2005 Sep 6‐9; Paris, France. 2005:41. ">MacDonald 2005</a>; <a href="./references#CD004731-bbs2-0024" title="RoseHJ , WhiteF , MacdonaldA , RutherfordPJ , FavreE . Fat intakes of children with PKU on low phenylalanine diets. Journal of Human Nutrition and Dietetics2005;18(5):395‐400. ">Rose 2005</a>; <a href="./references#CD004731-bbs2-0005" title="AgostoniC , HarvieA , McCullochDL , DemellweekC , CockburnF , GiovanniniM , et al. A randomized trial of long‐chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. Developmental Medicine and Child Neurology2006;48(3):207‐12. [MEDLINE: 16483397] ">Agostoni 2006</a>; <a href="./references#CD004731-bbs2-0010" title="ClearyMA , FeilletF , WhiteFJ , VidailhetM , MacdonaldA , GrimsleyA , et al. Randomised controlled trial of essential fatty acid supplementation in phenylketonuria. European Journal of Clinical Nutrition2006;60(7):915‐20. [MEDLINE: 16523206] ">Cleary 2006</a>; <a href="./references#CD004731-bbs2-0018" title="MacDonaldA , LilburnM , DaviesP , EvansS , DalyA , HallSK , et al. 'Ready to drink' protein substitute is easier is for people with phenylketonuria. Journal of Inherited Metabolic Disease2006;29(4):526‐31. [MEDLINE: 16736099] ">MacDonald 2006a</a>; <a href="./references#CD004731-bbs2-0022" title="MatalonR , Michals‐MatalonK , BurlinaA , GiovanniniM , FioriL , GrechaninaE , et al. Double blind placebo control trial in PKU with NeoPhe. Journal of Inherited Metabolic Disease2006;29(Suppl 1):13. ">Matalon 2006</a>; <a href="./references#CD004731-bbs2-0014" title="KoletzkoB , SauerwaldT , DemmelmairH , HerzogM , vonSchenckU , BohlesH , et al. Dietary long‐chain polyunsaturated fatty acid supplementation in infants with phenylketonuria: a randomized controlled trial. Journal of Inherited Metabolic Disease2007;30(3):326‐32. ">Koletzko 2007</a>; <a href="./references#CD004731-bbs2-0015" title="LevyH , MilanowskiA , ChakrapaniA , ClearyM , TrefzF , WhitleyC , et al. A phase 3 study of the efficacy of sapropterin in reducing phe levels in subjects with phenylketonuria. Journal of Inherited Metabolic Disease2006;29(Suppl 1):13. LevyHL , MilanowskiA , ChakrapaniA , ClearyM , LeeP , TrefzFK , et al. Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R‐BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo‐controlled study. Lancet2007;370(9586):504‐10. ">Levy 2007</a>; <a href="./references#CD004731-bbs2-0023" title="MatalonR , Michals‐MatalonK , BhatiaG , BurlinaAB , BurlinaAP , BragaC , et al. Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine. Journal of Inherited Metabolic Disease2007;30(2):153‐8. [MEDLINE: 17334706] ">Matalon 2007</a>; <a href="./references#CD004731-bbs2-0020" title="MacDonaldA , FergusonC , DalyA , HopkinsV , HallSK , RylanceG , HendrikszC , et al. Ready to use protein substitute for children with PKU. Journal of Inherited Metabolic Diseases2008; Vol. 31, issue Suppl 1:142. ">MacDonald 2008</a>; <a href="./references#CD004731-bbs2-0006" title="AhringKK , MxllerLB , NielsenJB , AndersenJR . Phenylketonuria‐‐the effects on quality of life and plasma concentrations of phenylalanine and tyrosine of two different amino‐acid‐supplementations in different concentrations. Journal of Inherited Metabolic Diseases2010; Vol. 33, issue Suppl 1:S104. ">Ahring 2010</a>; <a href="./references#CD004731-bbs2-0007" title="AhringKK , MxllerLB , AndersonJR . Phenylketonuria ‐ the effect of LNAA on amino acid profile [abstract]. Journal of Inherited Metabolic Diseases2012;S38:Abstract no: P‐052. ">Ahring 2012</a>; <a href="./references#CD004731-bbs2-0012" title="Gokmen‐OzelH , FergusonC , EvansS , DalyA , MacDonaldA . Does a lower carbohydrate protein substitute impact on blood phenylalanine control, growth and appetite in children with PKU?. Molecular Genetics and Metabolism2011;104:S64‐7. ">Gokmen‐Ozel 2011</a>; <a href="./references#CD004731-bbs2-0026" title="StroemP , EnggaardK , NielsenJB . When will PKU infants blood phenylalanine reach the desired level? ‐A study of 207 PKU patients. Journal of Inherited Metabolic Diseases2011; Vol. 34, issue Suppl 3:S101. ">Stroem 2011</a>; <a href="./references#CD004731-bbs2-0027" title="tenHoedtAE , deSonnevilleLM , FrancoisB , ter HorstNM , JanssenMC , Rubio‐GozalboME , et al. High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double‐blind, placebo‐controlled, crossover trial. Journal of Inherited Metabolic Diseases2011;34(1):165‐71. ">ten Hoedt 2011</a>); one was excluded because the participants did not meet inclusion criteria (<a href="./references#CD004731-bbs2-0013" title="KalkanogluHS , AhringKK , SertkayaD , MollerLB , RomstadA , MikkelsenI , et al. Behavioural effects of phenylalanine‐free amino acid tablet supplementation in intellectually disabled adults with untreated phenylketonuria. Acta Paediatrica2005;94(9):1218‐22. ">Kalkanoglu 2005</a>); two were excluded because the participants and intervention did not meet inclusion criteria (<a href="./references#CD004731-bbs2-0009" title="ClearyMA . Large neutral amino acids and phenylketonuria [abstract]. SHS Inborn Errors Review Series. 2003; Vol. Number 13. ">Cleary 2003</a>; <a href="./references#CD004731-bbs2-0021" title="MarsdenD , MulkernR , Young‐PoussaintT , RohrF , WaisbrenS . Large neutral amino acid treatment in adult patients with PKU ‐ a pilot study [abstract]. Society for the Study of Inborn Errors of Metabolism 42nd Annual Symposium; 2005 Sep 6‐9; Paris, France. 2005:22. ">Marsden 2005</a>); and one trial was excluded because the participants, intervention, and outcomes did not meet inclusion criteria (<a href="./references#CD004731-bbs2-0019" title="MacDonaldA , Gokmen OzelH , DalyA , HendrikszC , ChakrapaniA . Phenylalanine exchanges in PKU: should they be weighed?. Journal of Inherited Metabolic Disease2006;29(Suppl 1):39. MacDonaldA , Gokmen OzelH , DalyA , HendrikszC , ChakrapaniA . Phenylalanine exchanges in PKU: should they be weighed? [abstract]. Inborn Error Review Series (Dietary Management of Inborn Errors of Metabolism)2006; Vol. 16:12. ">MacDonald 2006c</a>). </p> <section id="CD004731-sec-0049"> <h5 class="title">Characteristics of studies awaiting classification</h5> <p>For the other three references (three trials), summary details for these trials, which are awaiting assessment, are available in the <a href="./references#CD004731-sec-0103" title="">Characteristics of studies awaiting classification</a> table. One trial is awaiting assessment as three participants were introduced to the trial after the initial randomisation phase (<a href="./references#CD004731-bbs2-0030" title="MacDonaldA , RylanceG , DaviesP , AsplinD , HallSK , BoothIW . Administration of protein substitute and quality of control in phenylketonuria: A randomized study. Journal of Inherited Metabolic Disease2003;26(4):319‐26. ">MacDonald 2003b</a>). The second and third trials were published as abstracts only and eligibility is unclear (<a href="./references#CD004731-bbs2-0028" title="GiovanniniM , FloriL , CaseroD , LammardoAM , BertolottiD , BonzaM , et al. Effects of a six month‐supplementation of a new phe‐free powdered amino acid preparation on blood amino acid profile and levels of albumin, protein and transferrin in PKU patients. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Giovannini 2006</a>; <a href="./references#CD004731-bbs2-0029" title="LangeA , StarosteckaE , HeleniakG , LukamowiczJ , KudraA . Bone metabolism in relation to dietary treatment in phenylketonuric (PKU) children aged 6‐8 years. [abstract]. Journal of Inherited Metabolic Disease2004;27(Suppl 1):18. [CENTRAL: 507906; CRS: 5500100000002702] ">Lange 2004</a>). The lead investigators of these trials will be contacted to request further information. </p> </section> </section> </section> <section id="CD004731-sec-0050"> <h3 class="title">Risk of bias in included studies</h3> <p>Assessment of methodological quality was based on a method described by Jüni (<a href="./references#CD004731-bbs2-0048" title="JüniP , AltmanDG , EggerM . Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ2001;323(7303):42‐6. ">Jüni 2001</a>). Additional information on the trials conducted by Prince, MacDonald, and Schindeler have been or will be requested by personal communication with the lead investigators, and it is hoped that further details can be included in a future update (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>; <a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>; <a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). Summary details including methodological quality of included studies are available in the <a href="./references#CD004731-sec-0101" title="">Characteristics of included studies</a> table. </p> <section id="CD004731-sec-0051"> <h4 class="title">Supplementation of a low‐phenylalanine diet with any dose of protein substitute that has been compared with no protein substitute </h4> <section id="CD004731-sec-0052"> <h5 class="title">Generation of allocation sequence</h5> <p>Generation of randomisation sequence was unclear in the included trial (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> <section id="CD004731-sec-0053"> <h5 class="title">Concealment of allocation</h5> <p>Allocation was concealed until the participant completed each arm of the trial (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> <section id="CD004731-sec-0054"> <h5 class="title">Blinding</h5> <p>Participants, investigators, and the operator who processed the MRS results were blinded to the treatment allocation (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> <section id="CD004731-sec-0055"> <h5 class="title">Intention‐to‐treat analysis</h5> <p>All stated participants completed the trial arms (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). All participant data were included except the dietary data for two participants in one trial who did not return their diet records (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> </section> <section id="CD004731-sec-0056"> <h4 class="title">Supplementation of a low phenylalanine diet with a dose of protein substitute compared with an alternative dose </h4> <section id="CD004731-sec-0057"> <h5 class="title">Generation of allocation sequence</h5> <p>Generation of randomisation sequence was considered to be adequate in the Prince trial as the sequence was generated using random number tables (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>); however, it was unclear in the MacDonald trial (<a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>). </p> </section> <section id="CD004731-sec-0058"> <h5 class="title">Concealment of allocation</h5> <p>Allocation of the intervention was concealed until the participants had been randomised in the two trials (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>; <a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>). </p> </section> <section id="CD004731-sec-0059"> <h5 class="title">Blinding</h5> <p>Neither participant nor investigator was blinded in the two trials (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>; <a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>). </p> </section> <section id="CD004731-sec-0060"> <h5 class="title">Intention‐to‐treat analysis</h5> <p>In one trial, one participant did not complete the intervention arm of the trial, and all data for this participant were excluded from the final analysis (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>). In the MacDonald trial, all stated participants completed the trial arms (<a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>). </p> </section> </section> <section id="CD004731-sec-0061"> <h4 class="title">Supplementation of a low‐phenylalanine diet with the same dose of protein substitution, but given as frequent small doses throughout the day compared with the same total daily dose given as larger boluses less frequently </h4> <p>No trials were eligible for inclusion.</p> </section> </section> <section id="CD004731-sec-0062"> <h3 class="title" id="CD004731-sec-0062">Effects of interventions</h3> <p>As stated in the '<a href="#CD004731-sec-0020">Methods</a>' section, data for the trials are not currently available for analysis, therefore results are presented narratively (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>; <a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>; <a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). Authors will be contacted for data needed to conduct analyses. </p> <section id="CD004731-sec-0063"> <h4 class="title">Supplementation of a low‐phenylalanine diet with any dose of protein substitute that has been compared with no protein substitute </h4> <section id="CD004731-sec-0064"> <h5 class="title">Primary outcomes</h5> <section id="CD004731-sec-0065"> <h6 class="title">1<i>.</i> Weight gain, body mass index, z scores, centiles, other indices of nutritional status or growth </h6> <p>This outcome was not measured in the included trial (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> <section id="CD004731-sec-0066"> <h6 class="title">2. Measures of neuropsychological performance</h6> <p>Attention, reaction time, response inhibition, generativity, self‐monitoring, cognitive flexibility, planning, immediate span, and working memory were assessed. Measures of attention were improved when taking protein substitute compared with not taking protein substitute. Data for protein substitute phases are not presented separately from LNAA arms; the author will be contacted for these data (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> </section> <section id="CD004731-sec-0067"> <h5 class="title">Secondary outcomes</h5> <section id="CD004731-sec-0068"> <h6 class="title">1<i>.</i> Blood phenylalanine concentrations </h6> <p>The median (range) plasma phenylalanine concentrations were significantly higher when participants did not take protein substitute (1180 (641 to 1744) µmol/L) compared with when they did take protein substitute (734 (19 to 1231) µmol/L) (P = 0.001) (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> <section id="CD004731-sec-0069"> <h6 class="title">2. Blood amino acid concentrations other than phenylalanine</h6> <p>Plasma amino acids other than phenylalanine were measured; however, only phenylalanine:tyrosine ratio data were presented. The median (range) plasma phenylalanine: tyrosine ratio was significantly higher when not taking protein substitute (30 (11.9 to 52.1)) compared with when taking protein substitute (14 (0.2 to 27.5)) (P &lt; 0.001). The authors stated that plasma amino acid concentrations of large neutral amino acids were increased when consuming MF compared with not consuming MF (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> <section id="CD004731-sec-0070"> <h6 class="title">3. Energy and nutrient intake</h6> <p>Median (range) intakes of total protein were higher (1.43 (0.88 to 1.85) g/kg/day versus 0.51 (0.17 to 0.62) g/kg/day) and protein from protein substitute were higher (0.94 (0.13 to 1.45) g/kg/day versus 0 (0 to 0) g/kg/day) in the arm on protein substitute compared with off protein substitute. Median (range) intakes of phenylalanine (18.5 (6.4 to 43.9) mg/kg/day versus 21.8 (6.2 to 27.9) mg/kg/day) and protein from food (0.40 (0.14 to 0.94) g/kg/day versus 0.51 (0.17 to 0.62) g/kg/day) were lower in the arm on protein substitute. The authors did not report the statistical significance of these differences. As noted earlier, the analysed dietary data include 14 of the 16 participants (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> <section id="CD004731-sec-0071"> <h6 class="title">4<i>.</i> Brain amino acid concentrations </h6> <p>Concentrations of phenylalanine in the brain between all arms of the trial ranged between 176 and 365 µmol/L. The authors reported no significant difference between trial arms, and arm‐specific data are not presented (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> <section id="CD004731-sec-0072"> <h6 class="title">5. Measures of eating behaviour</h6> <p>This outcome was not measured in the included trial (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> <section id="CD004731-sec-0073"> <h6 class="title">6<i>.</i> Measures of quality of life </h6> <p>This outcome was not measured in the included trial (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> <section id="CD004731-sec-0074"> <h6 class="title">7. Death</h6> <p>This outcome was not measured in the included trial (<a href="./references#CD004731-bbs2-0003" title="SchindelerS , Ghosh‐JerathS , ThompsonS , RoccaA , JoyP , KempA , et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Molecular Genetics and Metabolism2007;91(1):48‐54. [MEDLINE: 17368065] ThompsonS . Large neutral amino acid therapy for phenylketonuria in Australia. Proceedings of the Second International Metabolic Nutrition Conference; 2008 April 24‐26; Atlanta. Atlanta, 2008. ThompsonS , SchindelerS , Ghosh‐JerathS , RoccaA , JoyP , KempA , et al. Effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Journal of Inherited Metabolic Disease2006;29(Suppl 1):52. ">Schindeler 2007</a>). </p> </section> </section> </section> <section id="CD004731-sec-0075"> <h4 class="title">Supplementation of a low phenylalanine diet with a dose of protein substitute compared with an alternative dose </h4> <section id="CD004731-sec-0076"> <h5 class="title">Primary outcomes</h5> <section id="CD004731-sec-0077"> <h6 class="title">1<i>.</i> Weight gain, body mass index, z scores, centiles, other indices of nutritional status or growth </h6> <p>Height and weight centiles and protein status were measured during the Prince trial; however, it is unclear at which time points these were measured, and data were not presented. The authors commented that there were no clinical concerns of reduced growth or protein status during the combined phases of the trial (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>). Other outcomes of nutritional status were not measured (<a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>; <a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>). </p> </section> <section id="CD004731-sec-0078"> <h6 class="title">2. Measures of neuropsychological performance</h6> <p>This outcome was not measured in either of the included trials (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>; <a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>). </p> </section> </section> <section id="CD004731-sec-0079"> <h5 class="title">Secondary outcomes</h5> <section id="CD004731-sec-0080"> <h6 class="title">1<i>.</i> Blood phenylalanine concentrations </h6> <p>Blood phenylalanine concentrations were measured in both trials. The MacDonald trial showed a significant decrease in median plasma phenylalanine concentrations when on the higher dose of protein substitute (<a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>). Data for the RCT phase of the Prince trial were not presented separately (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>). </p> </section> <section id="CD004731-sec-0081"> <h6 class="title">2. Blood amino acid concentrations other than phenylalanine</h6> <p>Select serum amino acids other than phenylalanine (cystine, histidine, isoleucine, leucine, lysine, methionine, threonine, tyrosine, valine) were measured in one of the trials; however, data were not presented (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>). The author commented that no significant differences in mean serum amino acid concentrations were found between the control and experimental groups at entry or at the end of phase one (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>). </p> </section> <section id="CD004731-sec-0082"> <h6 class="title">3. Energy and nutrient intake</h6> <p>Energy and nutrient intake were measured in both trials. Data for the RCT phase of the Prince trial were not presented separately (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>). In the MacDonald trial, protein intake was only presented for the lower‐dose interventions, and energy was presented only as the difference between the two different interventions. The author has been contacted for the participant‐level data (<a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>). </p> </section> <section id="CD004731-sec-0083"> <h6 class="title">4<i>.</i> Brain amino acid concentrations </h6> <p>This outcome was not measured in either of the included trials (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>; <a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>). </p> </section> <section id="CD004731-sec-0084"> <h6 class="title">5. Measures of eating behaviour</h6> <p>This outcome was not measured in either of the included trials (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>; <a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>). </p> </section> <section id="CD004731-sec-0085"> <h6 class="title">6. Measures of quality of life</h6> <p>This outcome was not measured in either of the included trials (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>; <a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>). </p> </section> <section id="CD004731-sec-0086"> <h6 class="title">7<i>.</i> Death </h6> <p>This outcome was not measured in either of the included trials (<a href="./references#CD004731-bbs2-0002" title="BuistNR , PrinceAP , HuntingtonKL , TuerckJM , WaggonerDD . A new amino acid mixture permits new approaches to the treatment of phenylketonuria. Acta Paediatrica1994;407 Suppl:75‐7. [MEDLINE: 7766965] PrinceAP , McMurryMP , BuistNRM . Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. Journal of Inherited Metabolic Disease1997;20(4):486‐98. ">Prince 1997</a>; <a href="./references#CD004731-bbs2-0001" title="MacDonaldA , ChakrapaniA , HendrikszC , DalyA , DaviesP , AsplinD , et al. Protein substitute dosage in PKU: how much do young patients need?. Archives of Disease in Childhood2006;91(7):588‐93. [MEDLINE: 16547085] MacDonaldA , DalyA , ChakrapaniA , RylanceG , AsplinD , HallSK , et al. What is the ideal dose of protein substitute in PKU?. SHS Inborn Error Review Series2003, issue 13:15. ">MacDonald 2006b</a>). </p> </section> </section> </section> <section id="CD004731-sec-0087"> <h4 class="title">Supplementation of a low‐phenylalanine diet with the same dose of protein substitution, but given as frequent small doses throughout the day compared with the same total daily dose given as larger boluses less frequently </h4> <p>No trials were eligible for inclusion.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004731-sec-0088" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004731-sec-0088"></div> <p>Each trial included in this review contained small numbers of participants. In a future update of the review, it may be possible to include more data from these trials if provided by the authors. </p> <p>Although the Schindler trial conducted an intent‐to‐treat analysis on the primary outcome measures, two participants were excluded from the analysis of nutrient intakes due to missing data. The exclusion of these data may increase the risk for bias in these results, however the impact on the overall trial findings is likely to be low. </p> <p>Although little evidence has been found to support the use, the dosage, and the distribution of doses of protein substitute, this does not mean that these products are ineffective. Rather, the data available are insufficient to reach any conclusions regarding its use. Clinical experience and observational data have revealed that without protein substitute many people with PKU would not take sufficient protein to facilitate normal growth or body maintenance and control of blood phenylalanine. It is important to ascertain the quantity and quality of protein substitute required, as well as the frequency of administration to ensure optimal health, quality of life, and efficient use of healthcare resources. Improving the evidence to guide the use of protein substitute in PKU is helpful not only for the treatment of PKU, but as a model for the treatment of other aminoacidopathies. </p> </section> </section> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004731.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"/> </noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD004731-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD004731-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004731-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD004731-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="pl#CD004731-note-0003">Polski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"/> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"/> </a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004731\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004731\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004731\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004731\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004731\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004731.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004731.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004731.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004731.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004731.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718240483"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004731.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718240487"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004731.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dcb81bc93f3fd',t:'MTc0MDcxODI0MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 